Tech Company Financing Transactions
Ikerian Funding Round
Topcon Healthcare and private investors participated in a $6.2 million Series A venture round for Ikerian. The financing round was announced by the company on 5/2/2024.
Transaction Overview
Company Name
Announced On
5/2/2024
Transaction Type
Venture Equity
Amount
$6,180,000
Round
Series A
Investors
Topcon Healthcare (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support continued development and commercial roll out of RetinAI Discovery® in ophthalmology and optometry and for its expansion into new therapeutic areas prioritizing neurodegenerative disorders, vascular conditions and rare diseases.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Freiburgstrasse 3??
Bern, 3010
Switzerland
Bern, 3010
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
We enable the right decisions sooner in healthcare; Helping teams to harmonize and analyze healthcare data at scale to improve patient outcomes across the value chain. Our mission to tackle inefficiencies in healthcare with disease specific solutions has shaped our company and our ethos for improving outcomes for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carlos Ciller
Chief Scientific Officer
Sandro De Zanet
Chief Technical Officer
Stefanos Apostolopoulos
VP - Bus. Development
Aunia Grogan
VP - Finance
Christerlina Laing-Parisod
VP - Marketing
Nata�a Jovic
VP - Sales
Paris Hatzianastasiadis
Browse more venture capital transactions:
Prev: 5/2/2024: Mimic venture capital transaction
Next: 5/2/2024: Stargate Hydrogen venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs